Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer
Clinical trial NCT01494506 · COMPLETED
Trial details
- NCT number
- NCT01494506
- Sponsor
- Merrimack Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2014-02-01
- Enrollment
- 417
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.